Top 20 Global Corporations, 2010, Total Audited Markets, as per ORG IMS

Top 20 Global Corporations, 2010, Total Audited Markets
	2010 rank (US$)	2010 Sales (US$ MN)	2009 Sales (US$ MN)	2008 Sales (US$ MN)	2007 Sales (US$ MN)	2006 Sales (US$ MN)
Global Market	0	791,449$	752,022$	727,067$	671,164$	609,614$
PFIZER	1	55,602$	57,024$	58,677$	59,909$	59,415$
NOVARTIS	2	46,806$	38,460$	36,684$	34,479$	31,653$
MERCK & CO	3	38,468$	38,963$	39,488$	39,365$	35,965$
SANOFI-AVENTIS	4	35,875$	35,524$	36,437$	34,390$	31,843$
ASTRAZENECA	5	35,535$	34,434$	32,498$	29,999$	27,311$
GLAXOSMITHKLINE	6	33,664$	34,973$	36,736$	37,620$	36,212$
ROCHE	7	32,693$	32,763$	30,285$	27,232$	23,168$
JOHNSON & JOHNSON	8	26,773$	26,783$	29,638$	29,010$	27,615$
ABBOTT	9	23,833$	19,840$	19,401$	17,359$	15,971$
LILLY	10	22,113$	20,310$	19,042$	17,177$	15,176$
TEVA	11	21,064$	15,947$	15,143$	13,295$	11,664$
BAYER	12	15,656$	15,711$	15,887$	14,103$	12,329$
AMGEN	13	15,531$	15,038$	15,281$	15,900$	15,932$
BRISTOL-MYERS SQB.	14	14,977$	14,110$	13,559$	12,021$	11,348$
BOEHRINGER INGEL	15	14,591$	15,275$	14,109$	12,556$	11,320$
TAKEDA	16	12,983$	14,338$	13,833$	12,748$	11,783$
DAIICHI SANKYO	17	9,797$	8,773$	8,149$	7,180$	6,752$
NOVO NORDISK	18	9,719$	8,594$	7,941$	6,740$	5,762$
EISAI	19	8,757$	8,130$	7,109$	6,294$	5,798$
OTSUKA	20	8,732$	7,878$	6,456$	5,294$	4,643$
Source: IMS Health Midas, December 2010
US$: Sales and Rank are in US$ with quarterly exchange rates
Sales cover direct and indirect pharmaceutical channel wholesalers and manufacturers. The figures above include
prescription and certain over the counter data and represent manufacturer prices.